|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||2.2400 - 2.3000|
|52 Week Range||1.1900 - 5.7830|
|Beta (5Y Monthly)||0.88|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
NEW YORK and TORONTO , May 29, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE:TER, OTCQX: TRSSF), a leading North American cannabis operator, today provided an update regarding its previously announced US$30.0 million non-brokered private placement (the "Offering"). As a result of strong investor demand, the Company has upsized the offering to approximately US$37.0 million , which was oversubscribed and has been fully allocated. TerrAscend closed the second tranche of the Offering on May 28, 2020 , issuing 3,561 Units at an issue price of US$2,000 per Unit resulting in proceeds to the Company of US$7.1 million .
NEW YORK and TORONTO , May 25, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE:TER, OTCQX: TRSSF), a leading North American cannabis operator, today announced the closing of the first tranche of its previously announced non-brokered private placement ("the Offering"), issuing 13,646 Units at an issue price of US$2,000 per Unit resulting in proceeds to the Company of US$27.3 million . Each noninterest-bearing Unit is comprised of one convertible preferred share in the capital of the Company (each, a "Convertible Preferred Share") and one convertible preferred share purchase warrant (each, a "Warrant").
The Company has received initial investor commitments totaling US$28.0 million , including a US$20.0 million lead order from JW Asset Management LLC ("JW Asset Management") which is expected to close on or about May 21, 2020 , subject to customary closing conditions. The Company intends to use the proceeds from the Offering to fund TerrAscend's growth initiatives including its U.S. expansion strategy, capital expenditures, working capital, and general corporate purposes. The Offering consists of a number of units of the Company (each, a "Unit") issued at the price of $2,000 per Unit (the "Purchase Price").
NEW YORK and TORONTO , May 6, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER, OTCQX: TRSSF), a leading North American cannabis operator, today announced that Jason Ackerman , CEO and Executive Chairman, will be presenting at Canaccord Genuity's 4th Annual Global Cannabis Conference. In addition to the webcast presentation, Mr. Ackerman, Jason Wild , Chairman, and Keith Stauffer , Chief Financial Officer, will be conducting virtual one-on-one meetings with investors throughout the afternoon. The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release.
NEW YORK and TORONTO , May 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), a leading North American cannabis operator, today announced an expanded partnership with Precision Extraction Solutions ("Precision"). Through a newly signed agreement, Precision, a Detroit -based company with an extensive portfolio of cannabis extraction, refinement, and processing technologies, will provide state-of-the-art equipment for TerrAscend's current and future product lines. Precision is designing a multi-solvent lab in TerrAscend's New Jersey facility, currently under construction in Boonton Township .
TORONTO , April 24, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER, OTCQX: TRSSF), a leading North American cannabis operator, today announced the appointment of Keith Stauffer as Chief Financial Officer ("CFO"). Mr. Stauffer will be based in New York City and is expected to commence his role as CFO on April 27, 2020 , subject to CSE approval. Mr. Stauffer has over 25 years of experience as a business executive holding various senior finance and leadership roles across multiple industries.
NEW YORK, NY / ACCESSWIRE / April 24, 2020 / Terrascend Corp. (OTCMKTS:TRSSF) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on April 24, 2020 at 8:00 AM ...
TORONTO , April 14, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), a leading North American cannabis operator, announced today that it has appointed Jason Ackerman as Chief Executive Officer ("CEO"). The Company will also relocate its financial operations to its U.S. headquarters in New York City .
TORONTO , March 30, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company") a leading North American cannabis operator, today announced it will open its award-winning Apothecarium ("The Apothecarium") branded dispensaries in two Pennsylvania locations; one in Lancaster and a second in Plymouth Meeting . Both locations will serve Pennsylvania medical marijuana patients.
TORONTO , March 27, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), a leading North American Cannabis operator, today provided an update on the current state of its business amid the COVID-19 pandemic. Over the last two weeks, cannabis operations have been deemed essential in the jurisdictions in which TerrAscend is licensed, allowing the Company to remain fully operational and continue to serve customers and patients. To help service increased demand, the Company is hiring additional employees at its retail, cultivation, and processing facilities.
The selloff in the market and in Canopy Growth (NYSE:CGC) stock both continue. Markets plunged again earlier this week, and Canopy stock hasn't been immune to the selling pressure. Now, shares trade back where they did in 2017.Source: Jarretera / Shutterstock.com As I've argued over the past few weeks, investors need to keep their cool. This selloff has not been easy and certainly has not been fun. But over time, the economy and the markets will recover.In the meantime, however, the volatility is dispiriting. However, as I've told subscribers of my Cannabis Cash Weekly service, in these environments investors sometimes have to step back and let the chaos play out.InvestorPlace - Stock Market News, Stock Advice & Trading TipsTaking that step back, the opportunity in CGC stock becomes more clear. The long-term growth opportunity in cannabis is delayed -- not eliminated. Canopy is the industry's leader, and should remain so. In fact, it may emerge with an even stronger position. * 10 Stocks to Invest In for a Post-Coronavirus Whipsaw Canopy isn't going anywhere. This, too, shall pass -- and when it does, CGC stock will rally sharply. Canopy Cuts BackEven before panic gripped the markets, it was becoming increasingly clear that the cannabis industry was headed for a shakeout. And that shakeout is almost guaranteed at this point.In the sector as a whole, there is too much debt and too much capacity. Canopy chief executive officer David Klein made precisely that point in an interview on Feb. 14. "There's not a lot of market demand for cannabis production facilities," he told Yahoo! Finance. "There's a lot of capacity in Canada and no logical buyers."That capacity is why Canopy announced earlier this month that it was closing two facilities in British Columbia. Furthermore, a greenhouse project in Ontario also is being canceled. Canopy isn't throwing good money after bad.Wall Street largely cheered the move -- for good reason. It cuts Canopy's costs, and in turn, speeds its path toward profitability. It also keeps the company from participating in "race to the bottom" pricing in wholesale cannabis.It's also a decision many other cannabis companies won't be able to make. An Industry Shakeout LoomsCanopy can make that decision because of its fortress balance sheet. In 2018, Constellation Brands (NYSE:STZ,NYSE:STZ.B) invested some $4 billion into Canopy Growth.Much of that money has been spent. Canopy has made acquisitions, and spent heavily to build out production assets. In fact, it's clear in retrospect that previous management spent too much. That's a key reason why Constellation sent Klein -- formerly its chief financial officer -- to take the top spot at Canopy.However, Canopy still has a good chunk of that cash remaining. As of Dec. 31, the company had 2.3 billion CAD (about $1.6 billion) in cash on its balance sheet. With losses coming down and long-term debt of just 536 million CAD ($373 million), the company is in excellent financial shape.To put it simply, Canopy isn't going bankrupt -- but other producers will. There's a real chance the equity in Aurora Cannabis (NYSE:ACB) gets wiped out, one reason I've long recommended even cannabis bulls avoid that name. Moreover, MedMen Enterprises (OTCMKTS:MMNFF) had to call off its acquisition of PharmaCann -- likely due to financing worries. Its OTC stock price -- just 19 cents -- shows its desperate state.The news is just as bad, if not worse, for many smaller, private operators. Those companies don't have the cash to weather store closures or any short-term effects.Canopy, however, does. And that positions it well going forward. How CGC Stock Can BenefitCertainly, a worldwide pandemic is not how anyone hoped the cannabis industry would become more rational. But it's also likely that the response to the coronavirus from China simply will be the catalyst, not the cause. Given debt levels and overcapacity, many smaller operators were going to fail regardless.That said, Canopy would benefit either way. In fact, a recent transaction shows how. Last week, Canopy and TerrAscend (OTCMKTS:TRSSF) entered into a loan agreement. Canopy is lending TerrAscend 80.5 million CAD, backed by TerrAscend's assets.The loan has an interest rate of 6.1% annually over the next decade -- but that's not the prize. Canopy also received more than 17 million warrants to buy TerrAscend shares, most of them at an exercise price of 3.74 CAD per share.If TerrAscend, which currently trades below 2 CAD, posts a huge rally, Canopy will get its money back while also owning a nice chunk of the company at an attractive price.If it doesn't, though, Canopy has first claim on its assets, brands, and retail operations.This kind of savvy deal is what Klein was hired to make. And it highlights the opportunities Canopy will have for the next few years. The company can patiently wait out the upheaval in its industry, and pick its spots to make investments that can drive significant value.Of course, that's exactly what investors should be doing right now. As they do so, they should give at least a long look to Canopy Growth stock.Matthew McCall left Wall Street to actually help investors -- by getting them into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA) and +1,044% in Tesla (TSLA), just to name a few. Click here to see what Matt has up his sleeve now. Matt does not directly own the aforementioned securities. More From InvestorPlace * America's Richest ZIP Code Holds Wealth Gap Secret * 10 of the Best Long-Term Stocks to Buy in a Bear Market * 7 "Perfect 10" Healthcare Stocks to Buy Now * Where the FANG Stocks Sit in This Wild Market The post When the Smoke Clears, Canopy Growth Stock Will Be a Winner appeared first on InvestorPlace.
As Americans faced seclusion due to the COVID-19 pandemic, shoppers in San Francisco had the option of stocking up on one popular product with a minimal amount of human interaction: Marijuana.
Canopy Growth Corp. said Wednesday it has entered a loan financing agreement with TerrAscend Corp. for C$80.5 million ($58.8 million). As part of the deal, TerrAscend has issued 17.8 million warrants to purchase common stock. Canopy, the Canadian cannabis market leader, initially invested in TerrAscend in November 2017. Proceeds of the deal will be used to finance Canadian operations, its Arise Bioscience U.S. hemp division, international expansion, to repay debt and for general corporate purposes. Canopy shares were down 1.3% premarket and have fallen 69% in the last 12 months, while the ETFMG Alternative Harvest ETF has fallen 67% and the S&P 500 has gained 4%.
TORONTO , March 11, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend") (CSE:TER, OTCQX: TRSSF), today announced that TerrAscend Canada Inc. ("TerrAscend Canada"), its wholly owned subsidiary, has entered into a loan financing arrangement with Canopy Growth Corporation ("Canopy Growth" ) (TSX:WEED, NYSE:CGC) in the amount of C$80.5 million (the "Loan") pursuant to a secured debenture (the "Debenture"). In connection with the funding of the Loan, TerrAscend has issued 17,808,975 common share purchase warrants to Canopy Growth (the "Warrants"). Canopy Growth initially invested in TerrAscend in November 2017 alongside funds managed by TerrAscend Chairman Jason Wild .
TORONTO , Feb. 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), the first global cannabis company licensed for sales in the U.S., Canada , and the EU, announced today that the terms of its previously announced US$10 million loan (the "Loan") from Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of Canopy Rivers Inc. (TSX: RIV, OTC: CNPOF), to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly-owned subsidiary of TerrAscend, have been amended.
TORONTO , Jan. 30, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first global cannabis company licensed for sales in the U.S., Canada , and the EU, announced today that its majority owned subsidiary, TerrAscend Utah, LLC ("TerrAscend Utah") was awarded approval for a Medical Cannabis Processor License by the Utah Department of Agriculture and Food on January 29 , 2020. TerrAscend Utah's processing facility will be located in St George , Utah. "We are pleased St. George will have a company like TerrAscend in our community," said Jeriah Threlfall , President, St George Economic Development.
Jason Ackerman , Executive Chairman of the Company, has been named interim CEO, replacing Michael Nashat , who will continue to serve as a member of the Company's Board of Directors and act as a strategic advisor to the Company. The changes are effective immediately.
TORONTO , Jan. 27, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada , the U.S., and the EU, today announced the termination of the Securities Purchase Agreement (the "Agreement"), pursuant to which TerrAscend would have acquired all of the issued and outstanding equity interests of Gravitas Nevada Ltd. ("Gravitas"), a vertically-integrated business engaged in the cultivation, processing, packaging and dispensing of cannabis and cannabis related products in Nevada . Gravitas operates a retail cannabis dispensary in Las Vegas, Nevada under the trade name "The Apothecarium." The transaction, for $33 .5mm in cash and 625 proportionate voting shares in the equity of TerrAscend equivalent to 625,000 common shares of the Company, was originally announced on February 11 , 2019.
TerrAscend (CSE: TER) (OTCQX: TRSSF) announced that it has received a permit to cultivate medical marijuana from the New Jersey Department of Health. The company's subsidiary TerrAscend NJ will immediately begin cultivation operations at its facility in Boonton Township, located in northern New Jersey. TerrAscend NJ is the second entity to receive its cultivation permit among […]The post TerrAscend Gets Cultivation Permit in New Jersey appeared first on Market Exclusive.
TORONTO , Jan. 16, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada , the U.S., and the EU, today announced that TerrAscend NJ, LLC ("TerrAscend NJ") has been issued a permit to cultivate medical marijuana by the New Jersey Department of Health ("NJ DOH"). Cultivation operations will commence immediately at its facility in Boonton Township , located in northern New Jersey . In December 2018 , TerrAscend was awarded the right to apply for one of six permits, out of 146 applications, for a vertically-integrated permit to cultivate, process and dispense medical cannabis in the State of New Jersey .
TORONTO , Jan. 13, 2020 /CNW/ - TerrAscend Corp. (CSE:TER;) ("TerrAscend" or the "Company") has completed its previously announced upsized non-brokered private placement (the "Private Placement") with orders totaling an aggregate amount of approximately US$33.5 million , inclusive of the first tranche of the Private Placement which closed on December 30 , 2019. On January 10, 2019 , the Company closed the second tranche of the Private Placement, issuing 3,450,127 units (each, a "Unit") at an issue price of CAD$2.45 per Unit resulting in proceeds to the Company of CAD$8,452,811 .